Josh Hoffman is the founder of Zymergen. Zymergen has raised $1B in total funding. Latest round: IPO. Backed by SoftBank, Bill Ford.
Josh Hoffman is the co-founder and CEO of Zymergen, a biotechnology company that uses biology to produce materials typically derived from petrochemicals. He led the company from its seed round in 2013 through its IPO in 2021, raising over $1 billion in venture capital.
Full founder directory · Investor directory · Company funding database · Fundraising library